Trials / Unknown
UnknownNCT05182723
Evaluation of the Effectiveness of Extracorporeal Methods for Removing Mediators of Systemic Inflammation
Evaluation of the Effectiveness of Extracorporeal Methods for Removing Mediators of Systemic Inflammation in Patient With Multiple Organ Dysfunction Syndrome After Heart and Aortic Surgery
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 20 (estimated)
- Sponsor
- Petrovsky National Research Centre of Surgery · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to assess the effectiveness and the safety of extracorporeal methods for removing mediators of systemic inflammation in patients with multiple organ dysfunction syndrome after heart and aorta surgery.
Detailed description
After being informed about the study and potential risk, all patients with multiple organ dysfunction syndrome after heart and aorta surgery with indications for extracorporeal removal of inflammatory mediators, giving written informed consent will be included in the study. Patients will be randomized 1:1 ratio to 1. hemoperfusion cartridge for cytokine sorption in combination with an oXiris membrane and 2. oXiris membrane.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | renal replacement therapy | Extracorporeal Methods for Removing Mediators of Systemic Inflammation |
Timeline
- Start date
- 2021-11-25
- Primary completion
- 2024-11-30
- Completion
- 2025-05-31
- First posted
- 2022-01-10
- Last updated
- 2022-02-03
Locations
1 site across 1 country: Russia
Source: ClinicalTrials.gov record NCT05182723. Inclusion in this directory is not an endorsement.